Financials Regeneron Pharmaceuticals, Inc.

Equities

REGN

US75886F1075

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 20:12:00 09/07/2025 BST			5-day change	1st Jan Change
548.55 ^USD	+0.15%		+0.03%	-23.08%

07-07	RBC Raises Price Target on Regeneron Pharmaceuticals to $688 From $662, Keeps Sector Perform Rating	MT
07-02	Healthcare Stocks Declined Ahead of Jobs Report -- Healthcare Roundup	DJ

Projected Income Statement: Regeneron Pharmaceuticals, Inc.

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net sales ¹	8,497	16,072	12,173	13,117	14,202	13,473	14,365	15,792
Change	-	89.14%	-24.26%	7.76%	8.27%	-5.13%	6.62%	9.93%
EBITDA ¹	4,244	9,835	6,060	5,547	5,642	4,502	5,171	6,081
Change	-	131.7%	-38.38%	-8.47%	1.71%	-20.2%	14.84%	17.61%
EBIT ¹	3,577	8,947	5,719	5,126	5,159	3,932	4,510	5,661
Change	-	150.15%	-36.08%	-10.37%	0.64%	-23.78%	14.69%	25.51%
Interest Paid ¹	-56.9	-57.3	-59.4	-73	-55.2	-53.07	-54.5	-54.5
Earnings before Tax (EBT) ¹	3,810	9,326	4,859	4,199	4,780	3,743	4,513	5,342
Change	-	144.75%	-47.9%	-13.57%	13.83%	-21.69%	20.57%	18.37%
Net income ¹	3,513	8,075	4,338	3,954	4,413	3,151	3,550	4,382
Change	-	129.86%	-46.28%	-8.87%	11.61%	-28.58%	12.64%	23.43%
Announcement Date	05/02/21	04/02/22	03/02/23	02/02/24	04/02/25	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1
Net sales ¹	1,952	2,294	2,423	2,529	5,138	3,453	4,952	2,965	2,857	2,936	3,414	3,162	3,158	3,363	3,434	3,145	3,547	3,721	3,789	3,029	3,304	3,448	3,565	3,359	3,478	3,543	3,650	3,332
Change	-	17.52%	5.62%	4.37%	103.21%	-32.81%	43.41%	-40.12%	-3.64%	2.76%	16.29%	-7.39%	-0.13%	6.48%	2.13%	-8.42%	12.79%	4.89%	1.84%	-20.07%	9.09%	4.36%	3.4%	-5.78%	3.53%	1.87%	3.02%	-8.7%
EBITDA ¹	715.2	1,112	1,229	1,311	3,564	2,057	2,903	1,558	1,344	1,488	1,637	1,315	1,351	1,488	1,395	1,142	1,454	1,581	1,473	1,004	1,113	1,033	1,134	1,012	1,158	1,312	1,324	1,115
Change	-	55.54%	10.45%	6.7%	171.84%	-42.27%	41.09%	-46.33%	-13.71%	10.67%	10.04%	-19.69%	2.77%	10.13%	-6.23%	-18.16%	27.38%	8.71%	-6.86%	-31.84%	10.93%	-7.19%	9.71%	-10.69%	14.32%	13.35%	0.88%	-15.76%
EBIT ¹	656.4	1,053	1,167	1,113	3,347	1,847	2,640	1,483	1,285	1,413	1,537	1,215	1,248	1,382	1,282	1,028	1,334	1,459	1,346	876.9	997.5	1,059	1,002	949.9	993.1	1,075	1,106	988
Change	-	60.44%	10.82%	-4.65%	200.82%	-44.81%	42.9%	-43.8%	-13.35%	9.93%	8.78%	-20.95%	2.7%	10.78%	-7.26%	-19.84%	29.78%	9.42%	-7.75%	-34.87%	13.75%	6.18%	-5.39%	-5.21%	4.55%	8.21%	2.94%	-10.69%
Charge d'intérêts ¹	-9.7	-26.3	-14.8	-14.6	-14.4	-14.2	-14.1	-13.6	-13.1	-15.3	-17.4	-18	-18.9	-17.8	-18.3	-16.1	-14.8	-13.8	-10.5	-8.7	-10.65	-10.65	-20.55	-12.5	-12.5	-12.5	-12.5	-
Earnings before Tax (EBT) ¹	918.9	998.3	1,225	1,253	3,753	1,817	2,503	1,061	963.2	1,510	1,325	858	1,083	1,111	1,148	700.7	1,628	1,493	958.1	905	931.5	894.1	898.6	-	-	-	-	-
Change	-	8.64%	22.67%	2.32%	199.51%	-51.59%	37.81%	-57.61%	-9.23%	56.75%	-12.26%	-35.23%	26.21%	2.58%	3.31%	-38.94%	132.35%	-8.3%	-35.83%	-5.54%	2.93%	-4.01%	0.5%	-	-	-	-	-
Net income ¹	897.3	842.1	1,149	1,115	3,099	1,632	2,229	973.5	852.1	1,316	1,197	817.8	968.4	1,008	1,160	722	1,432	1,341	917.7	808.7	741.2	768.4	704.4	527.6	612.9	718.4	756	518.8
Change	-	-6.15%	36.47%	-2.96%	177.88%	-47.33%	36.56%	-56.33%	-12.47%	54.41%	-9.01%	-31.68%	18.42%	4.07%	15.06%	-37.74%	98.38%	-6.4%	-31.55%	-11.88%	-8.35%	3.68%	-8.34%	-25.09%	16.16%	17.21%	5.24%	-31.38%
Announcement Date	05/08/20	05/11/20	05/02/21	06/05/21	05/08/21	04/11/21	04/02/22	04/05/22	03/08/22	03/11/22	03/02/23	04/05/23	03/08/23	02/11/23	02/02/24	02/05/24	01/08/24	31/10/24	04/02/25	29/04/25	-	-	-	-	-	-	-	-

¹USD in Million

Estimates

Forecast Balance Sheet: Regeneron Pharmaceuticals, Inc.

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net Debt ¹	-891	-9,833	-	-8,862	-6,308	-9,261	-10,792	-13,502
Change	-	-1,003.59%	-	-	28.82%	-46.81%	-16.53%	-25.11%
Announcement Date	05/02/21	04/02/22	03/02/23	02/02/24	04/02/25	-	-	-

¹USD in Million

Estimates

Cash Flow Forecast: Regeneron Pharmaceuticals, Inc.

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
CAPEX ¹	614.6	551.9	590.1	718.6	755.9	838.6	830.1	778.9
Change	-	-10.2%	6.92%	21.78%	5.19%	10.94%	-1.01%	-6.18%
Free Cash Flow (FCF) ¹	2,004	6,529	4,425	3,875	3,665	5,232	4,496	5,675
Change	-	225.9%	-32.23%	-12.42%	-5.44%	42.77%	-14.06%	26.22%
Announcement Date	05/02/21	04/02/22	03/02/23	02/02/24	04/02/25	-	-	-

¹USD in Million

Estimates

Forecast Financial Ratios: Regeneron Pharmaceuticals, Inc.

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Profitability
EBITDA Margin (%)	49.95%	61.19%	49.79%	42.29%	39.73%	33.41%	36.16%	38.51%
EBIT Margin (%)	42.09%	55.67%	46.98%	39.08%	36.33%	29.26%	31.54%	35.85%
EBT Margin (%)	44.84%	58.03%	39.91%	32.01%	33.66%	27.77%	31.56%	33.83%
Net margin (%)	41.35%	50.25%	35.64%	30.14%	31.07%	23.38%	24.83%	27.75%
FCF margin (%)	23.58%	40.63%	36.35%	29.54%	25.8%	38.82%	31.45%	35.94%
FCF / Net Income (%)	57.03%	80.86%	101.99%	98.02%	83.05%	166.02%	126.66%	129.52%
Profitability
ROA	21.98%	37.91%	18.9%	16.2%	15.02%	9.9%	11.09%	13.8%
ROE	33.16%	54.21%	24.93%	20.74%	19.23%	12.7%	13.69%	14.86%
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	7.23%	3.43%	4.85%	5.48%	5.32%	6.22%	5.81%	4.93%
CAPEX / EBITDA (%)	14.48%	5.61%	9.74%	12.95%	13.4%	18.62%	16.05%	12.81%
CAPEX / FCF (%)	30.68%	8.45%	13.34%	18.54%	20.63%	16.03%	18.46%	13.72%
Items per share
Cash flow per share ¹	22.75	63.11	44.18	40.4	38.41	-	40.33	-
Change	-	177.47%	-29.99%	-8.55%	-4.95%	-	-	-
Dividend per Share ¹	-	-	-	-	-	2.832	3.016	3.01
Change	-	-	-	-	-	-	6.51%	-0.22%
Book Value Per Share ¹	102.5	177.6	211.6	241.4	272	304.7	330.5	361.5
Change	-	73.29%	19.18%	14.07%	12.7%	12.01%	8.46%	9.39%
EPS ¹	30.52	71.97	38.22	34.77	38.34	29.53	34.81	42.68
Change	-	135.81%	-46.89%	-9.03%	10.27%	-22.98%	17.88%	22.59%
Nbr of stocks (in thousands)	105,544	104,556	106,802	106,347	107,590	105,665	105,665	105,665
Announcement Date	05/02/21	04/02/22	03/02/23	02/02/24	04/02/25	-	-	-